Introduction

Continuing our successful Stability Challenges series, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for clinical trials and amorphous drug formulations
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors

You will leave this event with:
• Best practice and case studies from regulatory and industry experts
• Understanding of key developments, issues and strategies in drug stability
• Improve your stability laboratory compliance and efficiency
• New connections to experts and opinion leaders in this field
• Assure the stability of your medicines

Useful links

• Further event details More information about the event

Speakers

• Nigel McSweeney, Cuspor, Ireland
• Dr Niels Hartvig Novo Nordisk, United Kingdom
• Liselotte Kamper Novo Nordisk, United Kingdom
• Dr Garry Scrivens, Pfizer, United Kingdom
• Dr Samuel Kyeremateng NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany
• Dr Kristin Lehmkemper, NCE Formulation Sciences, AbbVie Deutschland GmbH, Germany

---

Sponsorship & supporting organisations

Royal Pharmaceutical Society and Royal Society of Chemistry

Venue

The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

• Venue information More information about the venue

Organised by

JPAG

Contact information

John Clements
JPAG
-
Contact us by email

---